Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 1Anxiety Disorders 1

Interventions

Surveys and Questionnaires 4Therapeutics 2Psilocybin 2Ketamine 2Ultraviolet Therapy 1Self-Help Groups 1Relaxation Therapy 1Psychotherapy 1Psychosocial Intervention 1Propranolol 1Oxygen 1Nitrous Oxide 1Niacin 1N-Methyl-3,4-methylenedioxyamphetamine 1Minocycline 1Midazolam 1Melatonin 1Interviews as Topic 1Imagery, Psychotherapy 1Hormones 1Exercise Test 1Early Intervention, Educational 1Donepezil 1Dehydroepiandrosterone 1Counseling 1Cognitive Behavioral Therapy 1Cannabidiol 1Autogenic Training 1Anesthesia, Local 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Anxiety Disorders × Hormones × Clear all
NCT04301089 2026-03-11

Immersive Virtual Reality (VR) at the Time of Clinical Evaluation to Improve Psychological Distress and Anxiety in Primary Brain Tumor (PBT) Patients

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
61 enrolled 20 charts
CNS

Anxiety Disorders, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡